Loading…
Advances in immunotherapy for glioblastoma multiforme
Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor of the central nervous system and has a very poor prognosis. The current standard of care for patients with GBM involves surgical resection, radiotherapy, and chemotherapy. Unfortunately, conventional therapies hav...
Main Authors: | , , , , , , , , |
---|---|
Format: | Online Article Text |
Language: | English |
Published: |
Frontiers Media S.A.
2022
|
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597698/ https://www.ncbi.nlm.nih.gov/pubmed/36311781 http://dx.doi.org/10.3389/fimmu.2022.944452 |